GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: AS-0017445
Compound class:
Synthetic organic
Comment: ASAP-0017445 is an antiviral with potential to treat pathogenic coronaviridae, including SARS-CoV-2 and MERS-CoV. It targets the virus' 3CL (main) protease (Mpro), and was discovered by the ASAP (artificial intelligence-driven structure-enabled antiviral platform) Discovery Consortium, that builds on work started through the COVID Moonshot, an open-source project that was initiated by the Drugs for Neglected Diseases initiative (DNDi). The chemical structure was disclosed at the 2025 Spring ACS meeting in San Diego [1], but no potency and efficacy data has yet been formally published (May 2025).
|
|
References |
1. Howes L.
Antiviral unveiled that goes after multiple coronaviruses. Accessed on 08/05/2025. Modified on 08/05/2025. cen.acs.org, https://cen.acs.org/acs-news/acs-meeting-news/Antiviral-unveiled-goes-multiple-coronaviruses/103/web/2025/03 |